Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 504 entries
Sorted by: Best Match Show Resources per page
Severe hyponatraemia during therapy with ramipril.

BMJ case reports

Ramasamy I.
PMID: 21918655
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.06.2009.1932. Epub 2009 Sep 15.

An older patient who was being treated with ramipril, chlorpromazine and aspirin presented with hypotension and serum sodium of 119 mmol/litre. The patient was treated with intravenous saline and all drug therapy was stopped. Serum sodium rose following fluid...

Cite
Ramasamy I. Severe hyponatraemia during therapy with ramipril. BMJ Case Rep. 2009;2009doi: 10.1136/bcr.06.2009.1932.
Ramasamy, I. (2009). Severe hyponatraemia during therapy with ramipril. BMJ case reports, 2009. https://doi.org/10.1136/bcr.06.2009.1932
Ramasamy, I. "Severe hyponatraemia during therapy with ramipril." BMJ case reports vol. 2009 (2009). doi: https://doi.org/10.1136/bcr.06.2009.1932
Ramasamy I. Severe hyponatraemia during therapy with ramipril. BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.06.2009.1932. Epub 2009 Sep 15. PMID: 21918655; PMCID: PMC3029881.
Copy Download .nbib Format: NLM
Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials.

BJPsych open

Zhao YJ, Lin L, Teng M, Khoo AL, Soh LB, Furukawa TA, Baldessarini RJ, Lim BP, Sim K.
PMID: 27703755
BJPsych Open. 2016 Feb 05;2(1):59-66. doi: 10.1192/bjpo.bp.115.002576. eCollection 2016 Jan.

BACKGROUND: For treatment of patients diagnosed with schizophrenia, comparative long-term effectiveness of antipsychotic drugs to reduce relapses when minimising adverse effects is of clinical interest, hence prompting this review.AIMS: To evaluate the comparative long-term effectiveness of antipsychotic drugs.METHOD: We...

Cite
Zhao YJ, Lin L, Teng M, et al. Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych Open. 2016;2(1):59-66doi: 10.1192/bjpo.bp.115.002576.
Zhao, Y. J., Lin, L., Teng, M., Khoo, A. L., Soh, L. B., Furukawa, T. A., Baldessarini, R. J., Lim, B. P., & Sim, K. (2016). Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych open, 2(1), 59-66. https://doi.org/10.1192/bjpo.bp.115.002576
Zhao, Ying Jiao, et al. "Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials." BJPsych open vol. 2,1 (2016): 59-66. doi: https://doi.org/10.1192/bjpo.bp.115.002576
Zhao YJ, Lin L, Teng M, Khoo AL, Soh LB, Furukawa TA, Baldessarini RJ, Lim BP, Sim K. Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych Open. 2016 Feb 05;2(1):59-66. doi: 10.1192/bjpo.bp.115.002576. eCollection 2016 Jan. PMID: 27703755; PMCID: PMC4995551.
Copy Download .nbib Format: NLM
Erratum to: Neuroprotection by Chlorpromazine and Promethazine in Severe Transient and Permanent Ischemic Stroke.

Molecular neurobiology

Geng X, Li F, Yip J, Peng C, Elmadhoun O, Shen J, Ji X, Ding Y.
PMID: 28660483
Mol Neurobiol. 2017 Dec;54(10):8151. doi: 10.1007/s12035-017-0656-6.

No abstract available.

Cite
Geng X, Li F, Yip J, et al. Erratum to: Neuroprotection by Chlorpromazine and Promethazine in Severe Transient and Permanent Ischemic Stroke. Mol Neurobiol. 2017;54(10):8151doi: 10.1007/s12035-017-0656-6.
Geng, X., Li, F., Yip, J., Peng, C., Elmadhoun, O., Shen, J., Ji, X., & Ding, Y. (2017). Erratum to: Neuroprotection by Chlorpromazine and Promethazine in Severe Transient and Permanent Ischemic Stroke. Molecular neurobiology, 54(10), 8151. https://doi.org/10.1007/s12035-017-0656-6
Geng, Xiaokun, et al. "Erratum to: Neuroprotection by Chlorpromazine and Promethazine in Severe Transient and Permanent Ischemic Stroke." Molecular neurobiology vol. 54,10 (2017): 8151. doi: https://doi.org/10.1007/s12035-017-0656-6
Geng X, Li F, Yip J, Peng C, Elmadhoun O, Shen J, Ji X, Ding Y. Erratum to: Neuroprotection by Chlorpromazine and Promethazine in Severe Transient and Permanent Ischemic Stroke. Mol Neurobiol. 2017 Dec;54(10):8151. doi: 10.1007/s12035-017-0656-6. PMID: 28660483.
Copy Download .nbib Format: NLM
Narcotic withdrawal syndrome of the neonate: comparison of treatment by chlorpromazine and diazepam.

Pediatric annals

Bauer CH.
PMID: 24849878
Pediatr Ann. 1973 Feb;2(2):43-7. doi: 10.3928/0090-4481-19730201-06.

No abstract available.

Cite
Bauer CH. Narcotic withdrawal syndrome of the neonate: comparison of treatment by chlorpromazine and diazepam. Pediatr Ann. 1973;2(2):43-7doi: 10.3928/0090-4481-19730201-06.
Bauer, C. H. (1973). Narcotic withdrawal syndrome of the neonate: comparison of treatment by chlorpromazine and diazepam. Pediatric annals, 2(2), 43-7. https://doi.org/10.3928/0090-4481-19730201-06
Bauer, C H. "Narcotic withdrawal syndrome of the neonate: comparison of treatment by chlorpromazine and diazepam." Pediatric annals vol. 2,2 (1973): 43-7. doi: https://doi.org/10.3928/0090-4481-19730201-06
Bauer CH. Narcotic withdrawal syndrome of the neonate: comparison of treatment by chlorpromazine and diazepam. Pediatr Ann. 1973 Feb;2(2):43-7. doi: 10.3928/0090-4481-19730201-06. PMID: 24849878.
Copy Download .nbib Format: NLM
A Facile Electrochemical Preparation of Reduced Graphene Oxide@Polydopamine Composite: A Novel Electrochemical Sensing Platform for Amperometric Detection of Chlorpromazine.

Scientific reports

Palanisamy S, Thirumalraj B, Chen SM, Wang YT, Velusamy V, Ramaraj SK.
PMID: 27650697
Sci Rep. 2016 Sep 21;6:33599. doi: 10.1038/srep33599.

We report a novel and sensitive amperometric sensor for chlorpromazine (CPZ) based on reduced graphene oxide (RGO) and polydopamine (PDA) composite modified glassy carbon electrode. The RGO@PDA composite was prepared by electrochemical reduction of graphene oxide (GO) with PDA....

Cite
Palanisamy S, Thirumalraj B, Chen SM, et al. A Facile Electrochemical Preparation of Reduced Graphene Oxide@Polydopamine Composite: A Novel Electrochemical Sensing Platform for Amperometric Detection of Chlorpromazine. Sci Rep. 2016;6:33599doi: 10.1038/srep33599.
Palanisamy, S., Thirumalraj, B., Chen, S. M., Wang, Y. T., Velusamy, V., & Ramaraj, S. K. (2016). A Facile Electrochemical Preparation of Reduced Graphene Oxide@Polydopamine Composite: A Novel Electrochemical Sensing Platform for Amperometric Detection of Chlorpromazine. Scientific reports, 633599. https://doi.org/10.1038/srep33599
Palanisamy, Selvakumar, et al. "A Facile Electrochemical Preparation of Reduced Graphene Oxide@Polydopamine Composite: A Novel Electrochemical Sensing Platform for Amperometric Detection of Chlorpromazine." Scientific reports vol. 6 (2016): 33599. doi: https://doi.org/10.1038/srep33599
Palanisamy S, Thirumalraj B, Chen SM, Wang YT, Velusamy V, Ramaraj SK. A Facile Electrochemical Preparation of Reduced Graphene Oxide@Polydopamine Composite: A Novel Electrochemical Sensing Platform for Amperometric Detection of Chlorpromazine. Sci Rep. 2016 Sep 21;6:33599. doi: 10.1038/srep33599. PMID: 27650697; PMCID: PMC5030524.
Copy Download .nbib Format: NLM
Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.

American journal of neurodegenerative disease

Lauterbach EC.
PMID: 27073741
Am J Neurodegener Dis. 2016 Mar 01;5(1):29-51. eCollection 2016.

Anxiety is common in the Mild Cognitive Impairment (MCI) stage of Alzheimer's disease (AD) and the pre-motor stages of Parkinson's disease (PD). A concomitant and possible cause of this anxiety is microglial activation, also considered a key promoter of...

Cite
Lauterbach EC. Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease. Am J Neurodegener Dis. 2016;5(1):29-51
Lauterbach, E. C. (2016). Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease. American journal of neurodegenerative disease, 5(1), 29-51.
Lauterbach, Edward C. "Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease." American journal of neurodegenerative disease vol. 5,1 (2016): 29-51.
Lauterbach EC. Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease. Am J Neurodegener Dis. 2016 Mar 01;5(1):29-51. eCollection 2016. PMID: 27073741; PMCID: PMC4788730.
Copy Download .nbib Format: NLM
Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and Disease.

Frontiers in aging neuroscience

Ferrer I, Garcia-Esparcia P, Carmona M, Carro E, Aronica E, Kovacs GG, Grison A, Gustincich S.
PMID: 27458372
Front Aging Neurosci. 2016 Jul 05;8:163. doi: 10.3389/fnagi.2016.00163. eCollection 2016.

Olfactory receptors (ORs) and down-stream functional signaling molecules adenylyl cyclase 3 (AC3), olfactory G protein α subunit (Gαolf), OR transporters receptor transporter proteins 1 and 2 (RTP1 and RTP2), receptor expression enhancing protein 1 (REEP1), and UDP-glucuronosyltransferases (UGTs) are...

Cite
Ferrer I, Garcia-Esparcia P, Carmona M, et al. Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and Disease. Front Aging Neurosci. 2016;8:163doi: 10.3389/fnagi.2016.00163.
Ferrer, I., Garcia-Esparcia, P., Carmona, M., Carro, E., Aronica, E., Kovacs, G. G., Grison, A., & Gustincich, S. (2016). Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and Disease. Frontiers in aging neuroscience, 8163. https://doi.org/10.3389/fnagi.2016.00163
Ferrer, Isidro, et al. "Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and Disease." Frontiers in aging neuroscience vol. 8 (2016): 163. doi: https://doi.org/10.3389/fnagi.2016.00163
Ferrer I, Garcia-Esparcia P, Carmona M, Carro E, Aronica E, Kovacs GG, Grison A, Gustincich S. Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and Disease. Front Aging Neurosci. 2016 Jul 05;8:163. doi: 10.3389/fnagi.2016.00163. eCollection 2016. PMID: 27458372; PMCID: PMC4932117.
Copy Download .nbib Format: NLM
The Effects of Prolactin-Raising and Prolactin-Sparing Antipsychotics on Prolactin Levels and Bone Mineral Density in Schizophrenic Patients.

Noro psikiyatri arsivi

Doğan Bulut S, Bulut S, Tüzer V, Ak M, Ak E, Kisa C, Aydemir Ç, Göka E.
PMID: 28360627
Noro Psikiyatr Ars. 2014 Sep;51(3):205-210. doi: 10.4274/npa.y6628. Epub 2014 Sep 01.

INTRODUCTION: We aimed to investigate the effects of antipsychotics on prolactin levels in patients diagnosed with schizophrenia and the effects of hyperprolactinemia on bone mineral density (BMD) in patients on long-term antipsychotics.METHOD: In this study, we included eighty consecutive...

Cite
Doğan Bulut S, Bulut S, Tüzer V, et al. The Effects of Prolactin-Raising and Prolactin-Sparing Antipsychotics on Prolactin Levels and Bone Mineral Density in Schizophrenic Patients. Noro Psikiyatr Ars. 2014;51(3):205-210doi: 10.4274/npa.y6628.
Doğan Bulut, S., Bulut, S., Tüzer, V., Ak, M., Ak, E., Kisa, C., Aydemir, �. �., & Göka, E. (2014). The Effects of Prolactin-Raising and Prolactin-Sparing Antipsychotics on Prolactin Levels and Bone Mineral Density in Schizophrenic Patients. Noro psikiyatri arsivi, 51(3), 205-210. https://doi.org/10.4274/npa.y6628
Doğan Bulut, Süheyla, et al. "The Effects of Prolactin-Raising and Prolactin-Sparing Antipsychotics on Prolactin Levels and Bone Mineral Density in Schizophrenic Patients." Noro psikiyatri arsivi vol. 51,3 (2014): 205-210. doi: https://doi.org/10.4274/npa.y6628
Doğan Bulut S, Bulut S, Tüzer V, Ak M, Ak E, Kisa C, Aydemir Ç, Göka E. The Effects of Prolactin-Raising and Prolactin-Sparing Antipsychotics on Prolactin Levels and Bone Mineral Density in Schizophrenic Patients. Noro Psikiyatr Ars. 2014 Sep;51(3):205-210. doi: 10.4274/npa.y6628. Epub 2014 Sep 01. PMID: 28360627; PMCID: PMC5353124.
Copy Download .nbib Format: NLM
A case of tinnitus induced by chlorpromazine in a pediatric patient.

Journal of pharmacology & pharmacotherapeutics

Carnovale C, Pellegrino P, Beretta S, Zuccotti GV, Perrone V, Antoniazzi S, Pozzi M, Clementi E, Radice S.
PMID: 24799822
J Pharmacol Pharmacother. 2014 Apr;5(2):163-5. doi: 10.4103/0976-500X.130110.

Chlorpromazine is a well-known antipsychotic agent that binds with a variety of receptors in the central nervous system. To date, chlorpromazine has never been associated with onset of hearing disorders and tinnitus. We report on an unexpected suspect adverse...

Cite
Carnovale C, Pellegrino P, Beretta S, et al. A case of tinnitus induced by chlorpromazine in a pediatric patient. J Pharmacol Pharmacother. 2014;5(2):163-5doi: 10.4103/0976-500X.130110.
Carnovale, C., Pellegrino, P., Beretta, S., Zuccotti, G. V., Perrone, V., Antoniazzi, S., Pozzi, M., Clementi, E., & Radice, S. (2014). A case of tinnitus induced by chlorpromazine in a pediatric patient. Journal of pharmacology & pharmacotherapeutics, 5(2), 163-5. https://doi.org/10.4103/0976-500X.130110
Carnovale, Carla, et al. "A case of tinnitus induced by chlorpromazine in a pediatric patient." Journal of pharmacology & pharmacotherapeutics vol. 5,2 (2014): 163-5. doi: https://doi.org/10.4103/0976-500X.130110
Carnovale C, Pellegrino P, Beretta S, Zuccotti GV, Perrone V, Antoniazzi S, Pozzi M, Clementi E, Radice S. A case of tinnitus induced by chlorpromazine in a pediatric patient. J Pharmacol Pharmacother. 2014 Apr;5(2):163-5. doi: 10.4103/0976-500X.130110. PMID: 24799822; PMCID: PMC4008917.
Copy Download .nbib Format: NLM
The induction of sporulation in the aquatic fungus blastocladiella emersonii is dependent on extracellular calcium.

FEMS microbiology letters

Coutinho EC, Correa LC.
PMID: 10518737
FEMS Microbiol Lett. 1999 Oct 15;179(2):353-9. doi: 10.1111/j.1574-6968.1999.tb08749.x.

Induction of sporulation in Blastocladiella emersonii is absolutely dependent on extracellular calcium. Vegetative cells grown in media with or without calcium do not sporulate in media devoid of calcium or in CaCl(2) with EGTA. Calcium channel blockers, CoCl(2) and...

Cite
Coutinho EC, Correa LC. The induction of sporulation in the aquatic fungus blastocladiella emersonii is dependent on extracellular calcium. FEMS Microbiol Lett. 1999;179(2):353-9doi: 10.1111/j.1574-6968.1999.tb08749.x.
Coutinho, E. C., & Correa, L. C. (1999). The induction of sporulation in the aquatic fungus blastocladiella emersonii is dependent on extracellular calcium. FEMS microbiology letters, 179(2), 353-9. https://doi.org/10.1111/j.1574-6968.1999.tb08749.x
Coutinho, and Correa. "The induction of sporulation in the aquatic fungus blastocladiella emersonii is dependent on extracellular calcium." FEMS microbiology letters vol. 179,2 (1999): 353-9. doi: https://doi.org/10.1111/j.1574-6968.1999.tb08749.x
Coutinho EC, Correa LC. The induction of sporulation in the aquatic fungus blastocladiella emersonii is dependent on extracellular calcium. FEMS Microbiol Lett. 1999 Oct 15;179(2):353-9. doi: 10.1111/j.1574-6968.1999.tb08749.x. PMID: 10518737.
Copy Download .nbib Format: NLM
Attempts to establish phencyclidine and cocaine discrimination without error.

Behavioural pharmacology

McMillan DE, Hardwick WC.
PMID: 11224081
Behav Pharmacol. 1991 Nov;2(4):379-389.

An attempt was made to train pigeons to discriminate phencyclidine (PCP) from saline using a three-key color-tracking procedure under which birds were trained under a second order schedule [FR10 (FR5)] "without errors." Training without errors was done by not...

Cite
McMillan DE, Hardwick WC. Attempts to establish phencyclidine and cocaine discrimination without error. Behav Pharmacol. 1991;2(4):379-389
McMillan, D. E., & Hardwick, W. C. (1991). Attempts to establish phencyclidine and cocaine discrimination without error. Behavioural pharmacology, 2(4), 379-389.
McMillan, D.E., and Hardwick, W.C.. "Attempts to establish phencyclidine and cocaine discrimination without error." Behavioural pharmacology vol. 2,4 (1991): 379-389.
McMillan DE, Hardwick WC. Attempts to establish phencyclidine and cocaine discrimination without error. Behav Pharmacol. 1991 Nov;2(4):379-389. PMID: 11224081.
Copy Download .nbib Format: NLM
Disruption of conditioned reaction time performance by dopamine receptor antagonists in the rat.

Behavioural pharmacology

Marrow L, Overton P, Clark D.
PMID: 11224167
Behav Pharmacol. 1993 Feb;4(1):15-28.

The effects of the neuroleptics haloperidol, cis-flupenthixol and chlorpromazine, and the selective dopamine (DA) receptor antagonists raclopride and SCH 23390, were assessed in a conditioned reaction time task. In this operant task, rats were required to hold down a...

Cite
Marrow L, Overton P, Clark D. Disruption of conditioned reaction time performance by dopamine receptor antagonists in the rat. Behav Pharmacol. 1993;4(1):15-28
Marrow, L., Overton, P., & Clark, D. (1993). Disruption of conditioned reaction time performance by dopamine receptor antagonists in the rat. Behavioural pharmacology, 4(1), 15-28.
Marrow, L., et al. "Disruption of conditioned reaction time performance by dopamine receptor antagonists in the rat." Behavioural pharmacology vol. 4,1 (1993): 15-28.
Marrow L, Overton P, Clark D. Disruption of conditioned reaction time performance by dopamine receptor antagonists in the rat. Behav Pharmacol. 1993 Feb;4(1):15-28. PMID: 11224167.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 504 entries